BDBM326568 US9662327, Compound 265
SMILES: CC(C)[C@@H]1CN(CCN1C(=O)Cc1cccnc1)c1nc(C2CC2)c2COC(C)(C)Cc2c1C#N
InChI Key: InChIKey=ATCMOSAJAAALAE-DEOSSOPVSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IDH1 R132H (Homo sapiens (Human)) | BDBM326568![]() (US9662327, Compound 265) | PDB GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Agios Pharmaceuticals Inc US Patent | Assay Description Assays were conducted in a volume of 76 μl assay buffer (150 mM NaCl, 10 mM MgCl2, 20 mM Tris pH 7.5, 0.03% bovine serum albumin) as follows in ... | US Patent US9662327 (2017) BindingDB Entry DOI: 10.7270/Q2RB76P0 | |||||||||||
More data for this Ligand-Target Pair |